Brief: Longeveron Receives Intent To Grant Notice From European Patent Office For Methods To Monitor Efficacy Of Lomecel-B Cell Therapy Through Levels Of Vascular Biomarker
25/08/2022 13:17
Aug 25 (Reuters) - Longeveron Inc LGVN.O :
* LONGEVERON RECEIVES INTENT TO GRANT NOTICE FROM THE
EUROPEAN
PATENT OFFICE FOR METHODS TO MONITOR EFFICACY OF LOMECEL-B™ CELL
THERAPY THROUGH LEVELS OF VASCULAR BIOMARKER
Source text for Eikon: ID:nGNXb3sg5c
Further company coverage: LGVN.O
((Reuters.Briefs@thomsonreuters.com;))